Roivant Sciences annual current ratio
2020
2021
2022
2023
2024
2025
Roivant Sciences Current Ratio Growth & History (ROIV)
Roivant Sciences's current ratio was 18.37 for fiscal 2025.
View full Roivant Sciences company overviewRoivant Sciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2026-03-31 | 18.37 | −15.09 | −45.10% |
| 2024 | 2025-03-31 | 33.47 | 8.23 | +32.61% |
| 2023 | 2024-03-31 | 25.24 | 18.63 | +282.27% |
| 2022 | 2023-03-31 | 6.60 | −5.04 | −43.30% |
| 2021 | 2022-03-31 | 11.64 | 1.65 | +16.57% |
| 2020 | 2021-03-31 | 9.99 | — | — |
Roivant Sciences quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-06-30 | 16.72 | −23.82 | −58.75% |
| Q4 2025 | 2026-03-31 | 18.37 | −15.09 | −45.10% |
| Q3 2025 | 2025-12-31 | 30.66 | −7.25 | −19.12% |
| Q2 2025 | 2025-09-30 | 33.70 | 23.28 | +223.19% |
| Q1 2025 | 2025-06-30 | 40.54 | 12.63 | +45.25% |
| Q4 2024 | 2025-03-31 | 33.47 | 8.23 | +32.61% |
| Q3 2024 | 2024-12-31 | 37.91 | 10.12 | +36.40% |
| Q2 2024 | 2024-09-30 | 10.43 | 4.59 | +78.48% |
| Q1 2024 | 2024-06-30 | 27.91 | 21.54 | +337.98% |
| Q4 2023 | 2024-03-31 | 25.24 | 18.63 | +282.27% |
| Q3 2023 | 2023-12-31 | 27.79 | 21.05 | +312.39% |
| Q2 2023 | 2023-09-30 | 5.84 | −1.59 | −21.38% |
| Q1 2023 | 2023-06-30 | 6.37 | 0.17 | +2.77% |
| Q4 2022 | 2023-03-31 | 6.60 | −5.04 | −43.30% |
| Q3 2022 | 2022-12-31 | 6.74 | −7.49 | −52.65% |
| Q2 2022 | 2022-09-30 | 7.43 | −0.99 | −11.76% |
| Q1 2022 | 2022-06-30 | 6.20 | −3.64 | −36.97% |
| Q4 2021 | 2022-03-31 | 11.64 | 1.65 | +16.57% |
| Q3 2021 | 2021-12-31 | 14.23 | — | — |
| Q2 2021 | 2021-09-30 | 8.42 | — | — |
| Q1 2021 | 2021-06-30 | 9.84 | — | — |
| Q4 2020 | 2021-03-31 | 9.99 | — | — |
Roivant Sciences current ratio trends
Over the last five fiscal years, Roivant Sciences's current ratio increased from 9.99 to 18.37, a change of 8.39. The latest reported quarter, Q1 2026, shows 16.72.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Roivant Sciences source filings ↗